Satellos Bioscience Inc
(MSCLF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -556 | -269 | -1,303 | -1,115 | -805 |
| Depreciation Amortization | 0 | 0 | 1 | 1 | 1 |
| Other Working Capital | -840 | -29 | 456 | 360 | 235 |
| Other Operating Activity | 1,247 | -2 | 1 | 2 | 2 |
| Operating Cash Flow | $-149 | $-301 | $-845 | $-753 | $-568 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-2 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 845 | 851 | N/A | N/A | N/A |
| Financing Cash Flow | $845 | $851 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 7 | 6 | -8 | N/A | 3 |
| Beginning Cash Position | 8 | 8 | 863 | 863 | 874 |
| End Cash Position | 9 | 563 | 8 | 110 | 309 |
| Net Cash Flow | $1 | $556 | $-856 | $-753 | $-566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -149 | -301 | -845 | -753 | -568 |
| Capital Expenditure | N/A | N/A | -2 | -2 | N/A |
| Free Cash Flow | -149 | -301 | -848 | -755 | -568 |